Table of Contents Global BRAF Kinase Inhibitors Market Research Report 2020, Forecast to 2025 1 Market Overview 1.1 BRAF Kinase Inhibitors Definition 1.1.1 Analysis of Macroeconomic Indicators 1.1.2 Years Considered 1.2 BRAF Kinase Inhibitors Segment by Type 1.2.1 Dabrafenib 1.2.2 Sorafenib 1.2.3 Vemurafenib 1.2.4 Encorafenib 1.3 Market Analysis by Application 1.3.1 Hospital 1.3.2 Medical Research Institute 1.3.3 Clinic 1.3.4 Other 1.4 Overview of Global BRAF Kinase Inhibitors Market 1.4.1 Global BRAF Kinase Inhibitors Revenue (2015-2025) 1.4.2 Global BRAF Kinase Inhibitors Production and Capacity (2015-2025) 1.4.3 North America BRAF Kinase Inhibitors Status and Prospect (2015-2025) 1.4.4 Europe BRAF Kinase Inhibitors Status and Prospect (2015-2025) 1.4.5 Japan BRAF Kinase Inhibitors Status and Prospect (2014-2025) 1.4.6 China BRAF Kinase Inhibitors Status and Prospect (2015-2025) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 1.5.4 Porter's Five Forces Analysis 1.5.5 SWOT Analysis 1.6 Coronavirus Disease 2019 (Covid-19): BRAF Kinase Inhibitors Industry Impact 1.6.1 How the Covid-19 is Affecting the BRAF Kinase Inhibitors Industry 1.6.2 BRAF Kinase Inhibitors Business Impact Assessment - Covid-19 1.6.3 Market Trends and BRAF Kinase Inhibitors Potential Opportunities in the COVID-19 Landscape 1.6.4 Measures / Proposal against Covid-19 2 Global BRAF Kinase Inhibitors Market Competition by Manufacturer 2.1 Global BRAF Kinase Inhibitors Sales and Market Share by Manufacturer (2018-2020) 2.2 Global BRAF Kinase Inhibitors Revenue and Market Share by Manufacturer (2018-2020) 2.3 Global BRAF Kinase Inhibitors Industry Concentration Ratio (CR5 and HHI) 2.4 Top 5 BRAF Kinase Inhibitors Manufacturer Market Share 2.5 Top 10 BRAF Kinase Inhibitors Manufacturer Market Share 2.6 Date of Key Manufacturers Enter into BRAF Kinase Inhibitors Market 2.7 Key Manufacturers BRAF Kinase Inhibitors Product Offered 2.8 Mergers & Acquisitions Planning 3 Analysis of BRAF Kinase Inhibitors Industry Key Manufacturers 3.1 Array BioPharma Inc. 3.1.1 Company Details 3.1.2 Product Information 3.1.3 Array BioPharma Inc. BRAF Kinase Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.1.4 Main Business Overview 3.1.5 Array BioPharma Inc. News 3.2 Bayer AG 3.2.1 Company Details 3.2.2 Product Information 3.2.3 Bayer AG BRAF Kinase Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.2.4 Main Business Overview 3.2.5 Bayer AG News 3.3 F. Hoffmann-La Roche Ltd. 3.3.1 Company Details 3.3.2 Product Information 3.3.3 F. Hoffmann-La Roche Ltd. BRAF Kinase Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.3.4 Main Business Overview 3.3.5 F. Hoffmann-La Roche Ltd. News 3.4 Novartis AG 3.4.1 Company Details 3.4.2 Product Information 3.4.3 Novartis AG BRAF Kinase Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.4.4 Main Business Overview 3.4.5 Novartis AG News 4 Global BRAF Kinase Inhibitors Market Size Categorized by Regions (2015-2020) 4.1 Global BRAF Kinase Inhibitors Sales Market Share by Region 4.2 Global BRAF Kinase Inhibitors Revenue Market Share by Region (2015-2019) 4.3 Global BRAF Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2015-2020) 4.4 North America BRAF Kinase Inhibitors Market Size Detail 4.4.1 North America BRAF Kinase Inhibitors Sales Growth Rate (2015-2020) 4.4.2 North America BRAF Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2015-2020) 4.5 Europe BRAF Kinase Inhibitors Market Size Detail 4.5.1 Europe BRAF Kinase Inhibitors Sales Growth Rate (2015-2020) 4.5.2 Europe BRAF Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2015-2020) 4.6 Japan BRAF Kinase Inhibitors Market Size Detail 4.6.1 Japan BRAF Kinase Inhibitors Sales Growth Rate (2015-2020) 4.6.2 Japan BRAF Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2015-2020) 4.7 China BRAF Kinase Inhibitors Market Size Detail 4.7.1 China BRAF Kinase Inhibitors Sales Growth Rate (2015-2020) 4.7.2 China BRAF Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2015-2020) 5 Global BRAF Kinase Inhibitors Market Segment by Type 5.1 Global BRAF Kinase Inhibitors Revenue, Sales and Market Share by Type (2015-2020) 5.1.1 Global BRAF Kinase Inhibitors Sales and Market Share by Type (2015-2020) 5.1.2 Global BRAF Kinase Inhibitors Revenue and Market Share by Type (2015-2020) 5.2 Dabrafenib Sales Growth Rate and Price 5.2.1 Global Dabrafenib Sales Growth Rate (2015-2020) 5.2.2 Global Dabrafenib Price (2015-2020) 5.3 Sorafenib Sales Growth Rate and Price 5.3.1 Global Sorafenib Sales Growth Rate (2015-2020) 5.3.2 Global Sorafenib Price (2015-2020) 5.4 Vemurafenib Sales Growth Rate and Price 5.4.1 Global Vemurafenib Sales Growth Rate (2015-2020) 5.4.2 Global Vemurafenib Price (2015-2020) 5.5 Encorafenib Sales Growth Rate and Price 5.5.1 Global Encorafenib Sales Growth Rate (2015-2020) 5.5.2 Global Encorafenib Price (2015-2020) 6 Global BRAF Kinase Inhibitors Market Segment by Application 6.1 Global BRAF Kinase Inhibitors Sales Market Share by Application (2015-2020) 6.2 Hospital Sales Growth Rate (2015-2020) 6.3 Medical Research Institute Sales Growth Rate (2015-2020) 6.4 Clinic Sales Growth Rate (2015-2020) 6.5 Other Sales Growth Rate (2015-2020) 7 BRAF Kinase Inhibitors Related Market Analysis 7.1 Upstream Analysis 7.1.1 Macro Analysis of Upstream Markets 7.1.2 Key Players in Upstream Markets 7.1.3 Upstream Market Trend Analysis 7.1.4 BRAF Kinase Inhibitors Manufacturing Cost Analysis 7.2 Downstream Market Analysis 7.2.1 Macro Analysis of Down Markets 7.2.2 Key Players in Down Markets 7.2.3 Downstream Market Trend Analysis 7.2.4 Sales Channel, Distributors, Traders and Dealers 8 Global BRAF Kinase Inhibitors Market Forecast 8.1 Global BRAF Kinase Inhibitors Sales, Revenue Forecast 8.1.1 Global BRAF Kinase Inhibitors Sales Growth Rate Forecast (2020-2025) 8.1.2 Global BRAF Kinase Inhibitors Revenue and Growth Rate Forecast (2020-2025) 8.1.3 Global BRAF Kinase Inhibitors Price and Trend Forecast (2020-2025) 8.2 Global BRAF Kinase Inhibitors Sales Forecast by Region (2020-2025) 8.2.1 North America BRAF Kinase Inhibitors Sales, Revenue Forecast (2020-2025) 8.2.2 Europe BRAF Kinase Inhibitors Sales, Revenue Forecast (2020-2025) 8.2.3 Japan BRAF Kinase Inhibitors Production, Revenue Forecast (2020-2025) 8.2.4 China BRAF Kinase Inhibitors Production, Revenue Forecast (2020-2025) 9 Research Findings and Conclusion 10 Appendix

List of Tables and Figures Figure BRAF Kinase Inhibitors Picture Table Global BRAF Kinase Inhibitors Sales by Type Figure Global Sales Market Share of BRAF Kinase Inhibitors by Product Type in 2019 Table Breakdown of BRAF Kinase Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3) Figure BRAF Kinase Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3) Figure Dabrafenib Picture Figure Sorafenib Picture Figure Vemurafenib Picture Figure Encorafenib Picture Table Global BRAF Kinase Inhibitors Sales by Application Figure Global BRAF Kinase Inhibitors Sales Market Share by Application in 2019 Figure Hospital Picture Figure Medical Research Institute Picture Figure Clinic Picture Figure Other Picture Table BRAF Kinase Inhibitors Market Size Comparison by Region (2019-2025) (K Units) & (Million US$) Figure Global BRAF Kinase Inhibitors Revenue (Million US$) (2015-2025) Figure Global BRAF Kinase Inhibitors Production (K Units) (2015-2025) Figure North America BRAF Kinase Inhibitors Revenue (Million US$) Growth Rate (2015-2025) Figure Europe BRAF Kinase Inhibitors Revenue (Million US$) Growth Rate (2015-2025) Figure Japan BRAF Kinase Inhibitors Revenue (Million US$) Growth Rate (2014-2025) Figure China BRAF Kinase Inhibitors Revenue (Million US$) Growth Rate (2015-2025) Table Market Opportunities in Next Few Years Table Market Risks Analysis Table Market Drivers Figure Porter's Five Forces Analysis Table SWOT Analysis Table Global BRAF Kinase Inhibitors Sales by Manufacturer (2018-2020) Figure Global BRAF Kinase Inhibitors Sales Market Share by Manufacturer in 2019 Table Global BRAF Kinase Inhibitors Revenue by Manufacturer (2018-2020) Figure Global BRAF Kinase Inhibitors Revenue Market Share by Manufacturer in 2019 Table Global BRAF Kinase Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI) Figure Top 5 BRAF Kinase Inhibitors Manufacturer (Revenue) Market Share in 2019 Figure Top 10 BRAF Kinase Inhibitors Manufacturer (Revenue) Market Share in 2019 Table Date of Key Manufacturers Enter into BRAF Kinase Inhibitors Market Table Key Manufacturers BRAF Kinase Inhibitors Product Type Table Mergers & Acquisitions Planning Table Array BioPharma Inc. Company Profile Figure BRAF Kinase Inhibitors Product Picture and Specifications of Array BioPharma Inc. Table BRAF Kinase Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020 Figure Array BioPharma Inc. BRAF Kinase Inhibitors Market Share (2018-2020) Table Array BioPharma Inc. Main Business Table Array BioPharma Inc. Recent Development Table Bayer AG Company Profile Figure BRAF Kinase Inhibitors Product Picture and Specifications of Bayer AG Table BRAF Kinase Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020 Figure Bayer AG BRAF Kinase Inhibitors Market Share (2018-2020) Table Bayer AG Main Business Table Bayer AG Recent Development Table F. Hoffmann-La Roche Ltd. Company Profile Figure BRAF Kinase Inhibitors Product Picture and Specifications of F. Hoffmann-La Roche Ltd. Table BRAF Kinase Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020 Figure F. Hoffmann-La Roche Ltd. BRAF Kinase Inhibitors Market Share (2018-2020) Table F. Hoffmann-La Roche Ltd. Main Business Table F. Hoffmann-La Roche Ltd. Recent Development Table Novartis AG Company Profile Figure BRAF Kinase Inhibitors Product Picture and Specifications of Novartis AG Table BRAF Kinase Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020 Figure Novartis AG BRAF Kinase Inhibitors Market Share (2018-2020) Table Novartis AG Main Business Table Novartis AG Recent Development Table Global BRAF Kinase Inhibitors Sales (K Units) by Region (2015-2020) Table Global BRAF Kinase Inhibitors Sales Market Share by Region (2015-2019) Figure Global BRAF Kinase Inhibitors Sales Market Share by Region (2015-2019) Figure Global BRAF Kinase Inhibitors Sales Market Share by Region in 2018 Table Global BRAF Kinase Inhibitors Revenue (Million US$) by Region (2015-2020) Table Global BRAF Kinase Inhibitors Revenue Market Share by Region (2015-2020) Figure Global BRAF Kinase Inhibitors Revenue Market Share by Region (2015-2020) Figure Global BRAF Kinase Inhibitors Revenue Market Share by Region in 2019 Table Global BRAF Kinase Inhibitors Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure North America BRAF Kinase Inhibitors Sales (K Units) Growth Rate (2015-2020) Figure Europe BRAF Kinase Inhibitors Sales (K Units) Growth Rate (2015-2020) Table Europe BRAF Kinase Inhibitors Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure Japan BRAF Kinase Inhibitors Sales (K Units) Growth Rate (2015-2020) Table Japan BRAF Kinase Inhibitors Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure China BRAF Kinase Inhibitors Sales (K Units) Growth Rate (2015-2020) Table China BRAF Kinase Inhibitors Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table Global BRAF Kinase Inhibitors Sales by Type (2015-2020) Table Global BRAF Kinase Inhibitors Sales Market Share by Type (2015-2020) Figure Global BRAF Kinase Inhibitors Sales Market Share by Type in 2019 Table Global BRAF Kinase Inhibitors Revenue by Type (2015-2020) Table Global BRAF Kinase Inhibitors Revenue Market Share by Type (2015-2020) Figure Global BRAF Kinase Inhibitors Revenue Market Share by Type in 2019 Figure Global Dabrafenib Sales Growth Rate (2015-2025) Figure Global Dabrafenib Price (2015-2020) Figure Global Sorafenib Sales Growth Rate (2015-2025) Figure Global Sorafenib Price (2015-2020) Figure Global Vemurafenib Sales Growth Rate (2015-2025) Figure Global Vemurafenib Price (2015-2020) Figure Global Encorafenib Sales Growth Rate (2015-2025) Figure Global Encorafenib Price (2015-2020) Table Global BRAF Kinase Inhibitors Sales Market Share by Application (2015-2020) Figure Global BRAF Kinase Inhibitors Sales Market Share by Application in 2019 Figure Global Hospital Sales Growth Rate (2015-2025) Figure Global Medical Research Institute Sales Growth Rate (2015-2025) Figure Global Clinic Sales Growth Rate (2015-2025) Figure Global Other Sales Growth Rate (2015-2025) Table Key Players of Upstream Markets Table Key Raw Materials Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of BRAF Kinase Inhibitors Table Key Players of Downstream Markets Figure Sales Channel Figure Global BRAF Kinase Inhibitors Production (K Units) Growth Rate Forecast (2020-2025) Figure Global BRAF Kinase Inhibitors Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Global BRAF Kinase Inhibitors Price and Trend Forecast (2020-2025) Table Global BRAF Kinase Inhibitors Sales (K Units) Forecast by Region (2020-2025) Figure Global BRAF Kinase Inhibitors Production Market Share Forecast by Region (2020-2025) Figure North America BRAF Kinase Inhibitors Sales (K Units) Growth Rate Forecast (2020-2025) Figure North America BRAF Kinase Inhibitors Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Europe BRAF Kinase Inhibitors Sales (K Units) Growth Rate Forecast (2020-2025) Figure Europe BRAF Kinase Inhibitors Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Japan BRAF Kinase Inhibitors Production (K Units) Growth Rate Forecast (2020-2025) Figure Japan BRAF Kinase Inhibitors Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure China BRAF Kinase Inhibitors Production (K Units) Growth Rate Forecast (2020-2025) Figure China BRAF Kinase Inhibitors Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Methodology/Research Approach Figure Market Size Estimation Figure Author List

Array BioPharma Inc. Bayer AG